May 7, 2015 | Opko Health announced that it will acquire Irish company EirGen Pharma for up to $135 million. Opko will reportedly pay $100 million in cash and $35 million in shares for EinGen, a pharmaceutical company that develops chemotherapy treatments. Opko operates in the US, Israel, Chile, Mexico, Uruguay and Spain and is headquartered in Miami, Florida.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments